Vasc Spec Int.  2014 Mar;30(1):5-10.

Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells

Affiliations
  • 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 2Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. docmin88@snu.ac.kr
  • 3Department of Surgery, Myongji Hospital, Goyang, Korea.

Abstract

PURPOSE
This study was designed to investigate whether vascular smooth muscle cells (VSMC) from the neointima showed any different response to antiproliferative agents, such as rapamycin or imatinib mesylate, compared to VSMCs from normal artery.
MATERIALS AND METHODS
Intimal hyperplasia was made by carotid balloon in jury in male rats. Neointimal cells at 4 weeks after injury and normal VSMCs were extracted by enzymatic isolation method and cultured. Cell viability and proliferation were tested in VSMCs from injured left carotid artery and uninjured right carotid artery. Tests were repeated with rapamycin, imatinib mesylate or both in various concentrations.
RESULTS
Rapamycin decreased cell viability only at a high concentration of 10(-5) M in uninjured VSMCs. Combined drugs decreased cell viability at a lower concentration of 10(-7) M in uninjured VSMCs, and at a higher concentration of 10(-5) M in neointimal cells. Overall, rapamycin showed cytocidal effects at a high concentration of 10(-5) M, whereas imatinib did not. Cell proliferation of neointima was significantly decreased along with the drug concentration. Cell proliferation of uninjured VSMCs was significantly decreased at higher drug concentrations. Combined drug therapy showed synergistic effects. Overall, neointimal cells are more susceptible to the antiproliferative effects of the drugs.
CONCLUSION
Neointimal cells from the injured carotid artery are more susceptible to the antiproliferative effect of imatinib and rapamycin. Both drugs can be a used for the prevention of intimal hyperplasia, which could be investigated through further in vivo studies.

Keyword

Imatinib; Sirolimus; Intimal hyperplasia; Neointimal cell; Carotid artery injury

MeSH Terms

Animals
Arteries
Carotid Arteries
Carotid Artery Injuries
Cell Proliferation
Cell Survival
Drug Therapy
Humans
Hyperplasia
Male
Mesylates*
Muscle, Smooth, Vascular*
Neointima
Rats
Sirolimus*
Imatinib Mesylate
Mesylates
Sirolimus
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr